Barclays’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $100M | Buy |
|
|||||
|
2025
Q2 | $93.5M | Buy |
|
|||||
|
2025
Q1 | $86.1M | Sell |
|
|||||
|
2024
Q4 | $88.4M | Sell |
|
|||||
|
2024
Q3 | $104M | Buy |
|
|||||
|
2024
Q2 | $101M | Sell |
|
|||||
|
2024
Q1 | $126M | Buy |
|
|||||
|
2023
Q4 | $99M | Buy |
|
|||||
|
2023
Q3 | $77.5M | Sell |
|
|||||
|
2023
Q2 | $113M | Buy |
|
|||||
|
2023
Q1 | $41.9M | Sell |
|
|||||
|
2022
Q4 | $69.1M | Buy |
|
|||||
|
2022
Q3 | $66.4M | Buy |
|
|||||
|
2022
Q2 | $62.5M | Sell |
|
|||||
|
2022
Q1 | $121M | Sell |
|
|||||
|
2021
Q4 | $252M | Buy |
|
|||||
|
2021
Q3 | $156M | Buy |
|
|||||
|
2021
Q2 | $97.9M | Buy |
|
|||||
|
2021
Q1 | $60.9M | Sell |
|
|||||
|
2020
Q4 | $77.4M | Buy |
|
|||||
|
2020
Q3 | $65M | Buy |
|
|||||
|
2020
Q2 | $34.7M | Sell |
|
|||||
|
2020
Q1 | $56.3M | Sell |
|
|||||
|
2019
Q4 | $80M | Sell |
|
|||||
|
2019
Q3 | $110M | Sell |
|
|||||
|
2019
Q2 | $149M | Buy |
|
|||||
|
2019
Q1 | $99.5M | Buy |
|
|||||
|
2018
Q4 | $66.8M | Buy |
|
|||||
|
2018
Q3 | $54.1M | Buy |
|
|||||
|
2018
Q2 | $32.7M | Sell |
|
|||||
|
2018
Q1 | $42.5M | Buy |
|
|||||
|
2017
Q4 | $33.3M | Buy |
|
|||||
|
2017
Q3 | $14.9M | Buy |
|
|||||
|
2017
Q2 | $12.3M | Sell |
|
|||||
|
2017
Q1 | $13.9M | Buy |
|
|||||
|
2016
Q4 | $8.98M | Buy |
|
|||||
|
2016
Q3 | $4.51M | Sell |
|
|||||
|
2016
Q2 | $13.2M | Buy |
|
|||||
|
2016
Q1 | $7.07M | Sell |
|
|||||
|
2015
Q4 | $11.4M | Buy |
|
|||||
|
2015
Q3 | $8.89M | Buy |
|
|||||
|
2015
Q2 | $7.12M | Sell |
|
|||||
|
2015
Q1 | $22.8M | Buy |
|
|||||
|
2014
Q4 | $8.64M | Buy |
|
|||||
|
2014
Q3 | $5.88M | Sell |
|
|||||
|
2014
Q2 | $9.88M | Buy |
|
|||||
|
2014
Q1 | $6.68M | Buy |
|
|||||
|
2013
Q4 | $5.79M | Sell |
|
|||||
|
2013
Q3 | $6.37M | Sell |
|
|||||
|
2013
Q2 | $8.63M | Buy |
|